Medications starting with
Poland-
The medicine is used topically for the treatment of skin diseases characterized by inflammation and itching, which respond to corticosteroid treatment.
Dosage form: ointment
Active substance Dosage betamethasone 0.5 mg/g ATC code: D07AC01
Manufacturer: Belupo s.r.o.
-
It is used to treat symptoms of an overactive bladder, such as a sudden and strong urge to urinate, frequent trips to the toilet, and urinary incontinence.
Dosage form: tablets, film-coated
Active substance Dosage solifenacin succinate 10 mg ATC code: G04BD08
Manufacturer: Belupo pharmaceuticals and cosmetics d.d.
-
It is used to treat symptoms of an overactive bladder, such as a sudden and strong urge to urinate, frequent urination, and urinary incontinence.
Dosage form: tablets, film-coated
Active substance Dosage solifenacin succinate 5 mg ATC code: G04BD08
Manufacturer: Belupo pharmaceuticals and cosmetics d.d.
-
The medicine is used for the topical treatment of skin diseases complicated by bacterial infection and responsive to corticosteroid treatment. It is intended for persons over 13 years of age.
Dosage form: ointment
Active substance Dosage betamethasone 0.5 mg/g gentamicin 1 mg/g ATC code: D07CC01
Manufacturer: Belupo s.r.o.
-
It is used for the topical treatment of skin diseases that are complicated by bacterial infection and respond to corticosteroid treatment. It is intended for individuals over 13 years of age.
Dosage form: ointment
Active substance Dosage betamethasone 0.5 mg/g gentamicin 1 mg/g ATC code: D07CC01
Manufacturer: Belupo s.r.o.
-
The medicine is used for the topical treatment of skin diseases that respond to corticosteroid treatment and are additionally complicated by bacterial infection. It is intended for individuals over 13 years of age.
Dosage form: cream
Active substance Dosage betamethasone 0.5 mg gentamicin 1 mg ATC code: D07CC01
Manufacturer: Belupo s.r.o.
-
The medicine is used topically for the treatment of skin diseases complicated by bacterial infection and responsive to corticosteroid treatment. It is intended for individuals over 13 years of age.
Dosage form: ointment
Active substance Dosage betamethasone 0,5 mg/g gentamicin 1 mg/g ATC code: D07CC01
Manufacturer: Belupo s.r.o.
-
The medicine is used topically for the treatment of skin diseases complicated by bacterial infection that respond to corticosteroid treatment. It is intended for individuals over 13 years of age.
Dosage form: cream
ATC code: D07CC01
Manufacturer: Belupo s.r.o.
-
The medicine is used topically for the treatment of skin diseases characterized by excessive keratinization, dryness, and inflammation that respond to corticosteroid treatment.
Dosage form: ointment
Active substance Dosage betamethasone 0.5 mg salicylic acid 30 mg ATC code: D07XC01
Manufacturer: Belupo s.r.o.
-
The medicine is used topically for the treatment of skin diseases characterized by excessive keratinization, dryness, and inflammation that respond to corticosteroid treatment.
Dosage form: solution for skin
Active substance Dosage betamethasone 0.5 mg salicylic acid 20 mg ATC code: D07XC01
Manufacturer: Belupo, s.r.o.
-
The medicine is used topically for the treatment of skin diseases characterized by excessive keratinization, dryness, and inflammation that respond to corticosteroid treatment.
Dosage form: ointment
Active substance Dosage betamethasone 0.5 mg/g salicylic acid 30 mg/g ATC code: D07XC01
Manufacturer: Belupo s.r.o.
-
The ointment is intended for the topical treatment of skin diseases characterized by excessive keratinization, dryness, and inflammation that respond to corticosteroid treatment.
Dosage form: ointment
Active substance Dosage betamethasone 0.5 mg/g salicylic acid 30 mg/g ATC code: D07XC01
Manufacturer: Belupo, s.r.o.
-
It is used topically for the treatment of skin diseases characterized by excessive keratinization, dryness, and inflammation that respond to corticosteroid treatment.
Dosage form: solution, topical
Active substance Dosage betamethasone 0.5 mg/g salicylic acid 20 mg/g ATC code: D07XC01
Manufacturer: Belupo s.r.o.
-
The medicinal product is used topically for the treatment of skin diseases characterized by excessive keratinization, dryness, and inflammation that respond to corticosteroid treatment.
Dosage form: ointment
Active substance Dosage betamethasone 0.5 mg/g salicylic acid 30 mg/g ATC code: D07XC01
Manufacturer: Belupo s.r.o.
-
The medicine is used topically to treat skin diseases characterized by excessive keratinization, dryness, and inflammation that respond to corticosteroid treatment.
Dosage form: solution, topical
Active substance Dosage betamethasone 0.5 mg/g salicylic acid 20 mg/g ATC code: D07XC01
Manufacturer: Belupo s.r.o.
-
The medicine is used to treat high blood pressure (hypertension) and in the treatment and prevention of symptoms of heart failure (such as shortness of breath, fatigue, or swelling of the ankles and feet).
Dosage form: tablets
Active substance Dosage enalapril maleate 10 mg ATC code: C09AA02
Manufacturer: Berlin-Chemie AG
-
The medicine is used to treat high blood pressure (hypertension) and in the treatment and prevention of symptoms of heart failure (such as shortness of breath, fatigue, or swelling of the ankles and feet).
Dosage form: tablets
Active substance Dosage enalapril maleate 20 mg ATC code: C09AA02
Manufacturer: Berlin-Chemie AG
-
The medicine is used to treat high blood pressure (hypertension) and in the treatment and prevention of symptoms of heart failure (such as shortness of breath, fatigue, or swelling of the ankles and feet).
Dosage form: tablets
Active substance Dosage enalapril maleate 5 mg ATC code: C09AA02
Manufacturer: Berlin-Chemie AG
-
The medicinal product is used for the treatment of chronic lymphocytic leukemia, non-Hodgkin lymphomas, and multiple myeloma.
Dosage form: powder for preparation of concentrate for infusion solution
Active substance Dosage bendamustine hydrochloride monohydrate 25 mg/vial or 100 mg/vial ATC code: L01AA09
Manufacturer: Accompagny Healthcare Polska Ltd.
-
The medicinal product is used to treat certain types of cancer: chronic lymphocytic leukaemia, non-Hodgkin lymphoma, and multiple myeloma.
Dosage form: solution for infusion, concentrate
Active substance Dosage bendamustine hydrochloride monohydrate 26.14 mg/ml ATC code: L01AA09
Manufacturer: Accompagny Healthcare Polska Ltd.
-
The medicinal product is used to treat certain types of cancer: chronic lymphocytic leukemia (when fludarabine chemotherapy is not indicated), non-Hodgkin lymphomas (which have not responded adequately to rituximab), and multiple myeloma (when treatment with thalidomide or bortezomib is inappropriate).
Dosage form: powder for preparation of concentrate for infusion solution
Active substance Dosage bendamustine hydrochloride monohydrate 2.5 mg/ml ATC code: L01AA09
Manufacturer: APL Swift Services (Malta) Ltd. Arrow Generiques Generis Farmacêutica, S.A.
-
The medicinal product is used to treat certain types of cancer: chronic lymphocytic leukemia, non-Hodgkin lymphomas, and multiple myeloma.
Dosage form: powder for preparation of concentrate for infusion solution
Active substance Dosage bendamustine hydrochloride monohydrate 25 mg/vial or 100 mg/vial ATC code: L01AA09
Manufacturer: Synthon Hispania S.L. Synthon s.r.o.
-
The medicinal product is used for the treatment of chronic lymphocytic leukemia, non-Hodgkin lymphomas, and multiple myeloma.
Dosage form: powder for preparation of concentrate for infusion solution
Active substance Dosage bendamustine hydrochloride 2.5 mg/ml ATC code: L01AA09
Manufacturer: Fresenius Kabi Deutschland GmbH
-
The medicinal product is used for the treatment of chronic lymphocytic leukemia, non-Hodgkin lymphomas, and multiple myeloma.
Dosage form: powder for preparation of concentrate for infusion solution
Active substance Dosage bendamustine 26.1 mg ATC code: L01AA09
Manufacturer: medac GmbH for Clinical Special Preparations
-
The medicinal product is used to treat certain types of cancer: chronic lymphocytic leukemia, non-Hodgkin lymphoma, and multiple myeloma.
Dosage form: powder for preparation of concentrate for infusion solution
Active substance Dosage bendamustine hydrochloride monohydrate 26.1 mg or 104.6 mg ATC code: L01AA09
Manufacturer: Synthon Hispania S.L. Synthon s.r.o.
-
The medicinal product is used in neonates, infants, children, and adolescents to restore normal fluid and electrolyte (salt) levels in the body, e.g., after surgery. It may serve as a plasma volume expander, help replenish fluid deficits, and act as a diluent for other drugs and electrolytes.
Dosage form: solution for infusion
Active substance Dosage sodium chloride 6.429 g potassium chloride 0,298 g calcium chloride dihydrate 0,147 g magnesium chloride hexahydrate 0,203 g sodium acetate trihydrate 4,082 g glucose monohydrate 11.0 g ATC code: B05BB02
Manufacturer: Fresenius Kabi Polska Sp. z o.o.
-
The medicinal product is used to prevent the effects of and treat the consequences of vitamin B deficiency in the body. This deficiency may result from improper nutrition, intensive dieting, hemodialysis, or chronic alcoholism.
Dosage form: tablets, coated
Active substance Dosage benfotiamine 50 mg ATC code: A11DA03
Manufacturer: Woerwag Pharma Production GmbH & Co. KG
-
The medicine is used to treat confirmed vitamin B deficiency, to prevent the effects of this deficiency in persons at risk, and to treat neuropathy and cardiovascular disorders caused by vitamin B deficiency.
Dosage form: tablets, film-coated
Active substance Dosage benfotiamine 300 mg ATC code: A11DA03
Manufacturer: Dragenopharm Apotheker Pueschl GmbH
-
The medicinal product is used as supportive treatment for, among others, neurological disorders of an inflammatory nature (neuritis), nerve pain (neuralgia), including those caused by diabetes or alcoholism, migraine, painful muscle strains, radiculitis, cervical or brachial neuralgia, herpes zoster, and facial nerve paralysis. It is also indicated for elderly patients and during convalescence.
Dosage form: tablets, film-coated
Active substance Dosage benfotiamine 40 mg pyridoxine hydrochloride 90 mg cyanocobalamin 0.25 mg ATC code: A11DB01
Manufacturer: Mako Pharma Sp. z o.o.
-
The medicine is used to relieve muscle and joint pain and stiffness caused by injury, strain, or inflammation, as well as in cases of lower back pain (lumbosacral region).
Dosage form: ointment
ATC code: M02AX10
Manufacturer: McNeil Healthcare (Ireland) Limited
-
It is used in the case of severe pain of various origins and fever, when other medicines are ineffective or cannot be used.
Dosage form: tablets
Active substance Dosage sodium metamizole monohydrate 500 mg thiamine hydrochloride 38.75 mg caffeine 50 mg ATC code: N02BB52
Manufacturer: Adipharm EAD
-
The medicine is used for the treatment of asthma (when pressurized or powder inhalers are inappropriate), croup syndrome (acute inflammation of the larynx, trachea, and bronchi with shortness of breath or a barking cough), and exacerbations of chronic obstructive pulmonary disease (COPD).
Dosage form: suspension for nebulization
Active substance Dosage budesonide 0,125 mg/ml ATC code: R03BA02
Manufacturer: Genetic S.p.A Pharmaceutical Works POLPHARMA S.A.
-
It is used in the treatment of asthma (when other forms of inhalation are inappropriate), croup syndrome (acute inflammation of the larynx, trachea, and bronchi manifesting as shortness of breath or a barking cough), and exacerbations of chronic obstructive pulmonary disease (COPD).
Dosage form: suspension for nebulization
Active substance Dosage budesonide 0,25 mg/ml ATC code: R03BA02
Manufacturer: Genetic S.p.A Pharmaceutical Works POLPHARMA S.A.
-
The medicine is used for the treatment of asthma (when pressurized or powder inhalers are inappropriate), croup syndrome (acute inflammation of the larynx, trachea, and bronchi with shortness of breath or a 'barking' cough), and exacerbations of chronic obstructive pulmonary disease (COPD).
Dosage form: suspension for nebulization
Active substance Dosage budesonide 0.50 mg/ml ATC code: R03BA02
Manufacturer: Genetic S.p.A Pharmaceutical Works POLPHARMA S.A.
-
The medicinal product is intended for the short-term, symptomatic treatment of occasional insomnia in adults.
Dosage form: tablets, film-coated
Active substance Dosage doxylamine hydrogen succinate 12.5 mg ATC code: R06AA09
Manufacturer: Industria Quimica y Farmaceutica VIR S.A. Pharmex Advanced Laboratories, S.L. STADA Arzneimittel AG STADA M&D SRL
-
It is used to treat confirmed vitamin B deficiency, to prevent this deficiency in persons at risk, and to treat neuropathy caused by the lack of this vitamin.
Dosage form: tablets
Active substance Dosage benfotiamine 300 mg ATC code: A11DA03
Manufacturer: Mako Pharma Sp. z o.o.
-
The medicinal product is intended for topical use on the skin for the treatment of various forms of acne vulgaris.
Dosage form: gel
Active substance Dosage benzoyl peroxide 10 g ATC code: D10AE01
Manufacturer: Medinfar Manufacturing S.A.
-
The medicinal product is intended for topical application to the skin for the treatment of various forms of acne vulgaris.
Dosage form: gel
Active substance Dosage benzoyl peroxide 5 g ATC code: D10AE01
Manufacturer: Orifarm Manufacturing Poland Sp. z o.o.
-
The medicine is used for the treatment of mild to moderate acne. It helps to fight the bacteria responsible for acne, treats blackheads, and reduces the number of red, inflamed pustules.
Dosage form: gel
Active substance Dosage clindamycin 10 mg/g benzoyl peroxide 50 mg/g ATC code: D10AF51
Manufacturer: Jadran-Galenski laboratorij d.d. Orifarm Generics A/S
-
The medicinal product is used in adults and children over 6 years of age for the local relief of acute sore throat and inflammatory conditions, such as redness or swelling in the mouth and throat.
Dosage form: aerosol, oral solution
Active substance Dosage benzydamine hydrochloride 1.5 mg/ml ATC code: A01AD02
Manufacturer: Laboratorium Sanitatis S.L. MCM Klosterfrau Vertriebsgesellschaft mbH Pharmex Advanced Laboratories, S.L.
-
The medicinal product is used in adults for the local relief of acute sore throat and inflammatory symptoms, such as pain, redness, or swelling in the mouth and throat.
Dosage form: aerosol, oral solution
Active substance Dosage benzydamine hydrochloride 3 mg/ml ATC code: A01AD02
Manufacturer: Laboratorium Sanitatis S.L. MCM Klosterfrau Vertriebsgesellschaft mbH Pharmex Advanced Laboratories, S.L.
-
The medicine is used for the local relief of acute sore throat accompanied by inflammation, i.e., pain, redness, or swelling in the mouth and throat.
Dosage form: tablets, hard
Active substance Dosage benzydamine hydrochloride 3 mg ATC code: R02AX03
Manufacturer: Klosterfrau Berlin GmbH
-
The medicine is used for the local relief of acute throat pain and inflammatory symptoms, such as pain, redness, or swelling in the oral cavity and throat.
Dosage form: tablets, hard
Active substance Dosage benzydamine hydrochloride 3 mg ATC code: R02AX03
Manufacturer: Klosterfrau Berlin GmbH
-
The medicine is used for the treatment and disinfection of various types of superficial wounds where there is a risk of infection (e.g., scratches, cuts, abrasions, burns, diaper rash, dermatitis) and for the treatment of wounds after minor surgical procedures.
Dosage form: cream
Active substance Dosage dexpanthenol 50 mg/g chlorhexidine dihydrochloride 5 mg/g ATC code: D08AC02
Manufacturer: Bayer Portugal, Ltd.
-
The medicinal product is used for the treatment and disinfection of various types of superficial wounds when there is a risk of infection (such as scratches, cuts, abrasions, skin cracks, burns, or diaper rash) and for the treatment of wounds after minor surgical procedures.
Dosage form: cream
Active substance Dosage dexpanthenol 50 mg/g chlorhexidine dihydrochloride 5 mg/g ATC code: D08AC52
Manufacturer: UAB Bayer
-
The medicine is used in men to treat moderate or severe symptoms related to urination and bladder storage, caused by bladder problems and an enlarged prostate (benign prostatic hyperplasia). It is used when treatment with a single drug has not provided sufficient improvement.
Dosage form: tablets, modified release
Active substance Dosage solifenacin succinate 6 mg tamsulosin hydrochloride 0.4 mg ATC code: G04CA53
Manufacturer: Genericon Pharma Gesellschaft m.b.H., Synthon B.V., Synthon Hispania S.L., Synthon s.r.o.
-
Beriate is used for the prophylaxis and treatment of bleeding caused by a deficiency of coagulation factor VIII (hemophilia type A) and in the treatment of acquired deficiency of this factor. The drug helps to temporarily improve blood clotting mechanisms.
Dosage form: solution for injection / infusion, powder and solvent for preparation of
ATC code: B02BD02
Manufacturer: CSL Behring GmbH
-
The medicine is used to treat and prevent the occurrence of swelling (edema) during procedures in individuals suffering from hereditary angioedema type I and II.
Dosage form: solution for injection, powder and solvent for preparation of
Active substance Dosage human c1 esterase inhibitor 450-625 IU/ml ATC code: B02AB03
Manufacturer: CSL Behring GmbH
-
The medicinal product is used for the prevention of recurrent attacks of hereditary angioedema (HAE) in adolescents and adults.
Dosage form: solution for injection, powder and solvent for preparation of
Active substance Dosage human c1 esterase inhibitor 2000 j.m. ATC code: B06AC01
Manufacturer: CSL Behring GmbH
-
The medicine is used for protection against recurrent attacks of hereditary angioedema (HAE) in adolescents and adults.
Dosage form: solution for injection, powder and solvent for preparation of
Active substance Dosage human c1 esterase inhibitor 3000 j.m. ATC code: B06AC01
Manufacturer: CSL Behring GmbH